Gastrointestinal Cancer,Liver Cancer Cost-effectiveness of HCC treatments: Sintilimab + Bevacizumab vs. Lenvatinib Mar 10, 2023
Gastrointestinal Cancer,Liver Cancer Cabozantinib and Durvalumab Combo Shows Promise for GI Malignancies: CAMILLA Trial Mar 10, 2023
Gastrointestinal Cancer,Liver Cancer Analyzing the Exposure-Response of Tremelimumab and Durvalumab in Patients with Unresectable HCC Feb 16, 2023
